It defends against free radicals produced within the mitochondria (power plants) of cells
In terms of side effects and tolerability, the advantage goes to Tirzepatide
All relevant studies ( Semaglutide is the only GLP-1RA that has been approved in an oral form, that is something very important reinforcing the compliance of the patients compared to the injectable forms
Based on GLP-1 nasal delivery research, intranasal retatrutide would likely require daily or multiple-times-daily administration
Similarly, several studies demonstrated the ability of GLP-1RAs to decrease self-administration of opioids, such as heroin [28-31], oxycodone [32], and fentanyl [33-36], in rodent models of OUD
A healthcare provider will review your information to determine if you qualify for prescription medication